A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

NCT06476509 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LV232 40mg
DRUG: Escitalopram 20 mg
DRUG: LV232 60mg
DRUG: LV232 20mg

Sponsor

Vigonvita Life Sciences